Etiology and management of hypertension in patients with cancer
Abstract The pathophysiology of hypertension and cancer are intertwined. Hypertension has been associated with an increased likelihood of developing certain cancers and with higher cancer-related mortality. Moreover, various anticancer therapies have been reported to cause new elevated blood pressur...
Main Authors: | Turab Mohammed, Meghana Singh, John G. Tiu, Agnes S. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Cardio-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40959-021-00101-2 |
Similar Items
-
Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management
by: Amir Askarinejad, et al.
Published: (2023-12-01) -
Vascular endothelial growth factor-tyrosine kinase inhibitors: Novel mechanisms, predictors of hypertension and management strategies
by: Javier A. Gomez
Published: (2022-05-01) -
Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer
by: Yuma Shibutani, et al.
Published: (2023-11-01) -
Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development
by: Daniel Pinkhas, et al.
Published: (2017-06-01) -
Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model
by: Amber Kempton, et al.
Published: (2018-08-01)